NEW YORK: Pfizer said that several agencies are involved in a global pitch for Lipitor, the blockbuster cholesterol drug facing patent expiration in 2011.
MacKay Jimeson, media relations manager for Pfizer, confirmed the review. He declined to provide further comment but noted that reviews "ensure that we have the best teams in place to support our products."
The global RFP focuses on the loss of Lipitor's US exclusivity in November and its impact on Pfizer, say sources. The US market generated ...